Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Celularity Inc: Stockholders approved an amendment to the Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by recent amendments to Delaware law (effective 2023-06-14).
- Change
- charter amendment
- Effective
- 2023-06-14
Exact text from the filing
At the 2023 annual meeting of stockholders of Celularity Inc., or Celularity, held on June 14, 2023, or the Annual Meeting, the stockholders of Celularity approved an amendment to Celularity’s Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers of Celularity as permitted by recent amendments to Delaware law.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Celularity Inc shareholders approved Elect Dean C. Kehler, Robin L. Smith, M.D., and Lim Kok Thay as Class II Directors at the 2023-06-16 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-16
Exact text from the filing
Proposal 1. Stockholders elected the following nominees to serve as the Class II Directors on Celularity’s Board of Directors until its 2026 Annual Meeting of Stockholders or until his or her respective successor has been duly elected and qualified or until his or her earlier death, resignation or removal. The voting results for the nominees were as follows: Director Name Votes For Votes Withheld Broker Non-Votes Dean C. Kehler 109,020,056 5,784,735 37,744,783 Robin L. Smith, M.D. 111,579,526 3,221,173 37,748,875 Lim Kok Thay 106,756,423 8,044,276 37,748,875
View on SEC.gov